Takeda Pharmaceutical Company Limited approved a year-end dividend of 100 JPY per share at its 150th Annual General Meeting of Shareholders. The meeting also saw the re-election of six directors and the election of new directors Julie Kim and Paul Stoffels, along with the election of three Audit and Supervisory Committee members. The company operates in the pharmaceutical industry and develops and manufactures medicines.
